Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Karen J. Wilson currently holds 15,250 shares of Elicio Therapeutics, Inc. (ELTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen J. Wilson has been a net seller of ELTX stock. They have purchased $54.7K and sold $11.5M worth of shares.
Karen J. Wilson's most recent insider trade was on Jun 17, 2026, when they sold 15,250 shares at $0.00 per share.
Karen J. Wilson serves as Executive at Elicio Therapeutics, Inc. (ELTX). They have executed 79 insider transactions totaling $11.6M over their tenure at the company.
Karen J. Wilson holds the position of Executive at Elicio Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Karen J. Wilson has shown a selling trading pattern, with $54.7K in total purchases and $11.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Karen J. Wilson was on Apr 10, 2017, when they sold $1.0M worth of JAZZ shares. This transaction involved 6,708 shares at $152.24 per share.
Karen J. Wilson currently owns 15,250 shares of Elicio Therapeutics, Inc. (ELTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Karen J. Wilson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Karen J. Wilson has 79 Form 4 filings on record as an insider at Elicio Therapeutics, Inc..
Set alerts for Karen J. Wilson and 40,000+ other insiders.